1. Home
  2. CRNX vs KTOS Comparison

CRNX vs KTOS Comparison

Compare CRNX & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • KTOS
  • Stock Information
  • Founded
  • CRNX 2008
  • KTOS 1994
  • Country
  • CRNX United States
  • KTOS United States
  • Employees
  • CRNX N/A
  • KTOS N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • KTOS Military/Government/Technical
  • Sector
  • CRNX Health Care
  • KTOS Industrials
  • Exchange
  • CRNX Nasdaq
  • KTOS Nasdaq
  • Market Cap
  • CRNX 2.8B
  • KTOS 10.0B
  • IPO Year
  • CRNX 2018
  • KTOS 1999
  • Fundamental
  • Price
  • CRNX $34.20
  • KTOS $75.74
  • Analyst Decision
  • CRNX Strong Buy
  • KTOS Strong Buy
  • Analyst Count
  • CRNX 7
  • KTOS 14
  • Target Price
  • CRNX $74.33
  • KTOS $56.79
  • AVG Volume (30 Days)
  • CRNX 1.1M
  • KTOS 2.9M
  • Earning Date
  • CRNX 11-11-2025
  • KTOS 11-06-2025
  • Dividend Yield
  • CRNX N/A
  • KTOS N/A
  • EPS Growth
  • CRNX N/A
  • KTOS 31.73
  • EPS
  • CRNX N/A
  • KTOS 0.09
  • Revenue
  • CRNX $1,392,000.00
  • KTOS $1,213,100,000.00
  • Revenue This Year
  • CRNX $489.51
  • KTOS $17.66
  • Revenue Next Year
  • CRNX $661.93
  • KTOS $18.10
  • P/E Ratio
  • CRNX N/A
  • KTOS $801.87
  • Revenue Growth
  • CRNX 0.51
  • KTOS 7.76
  • 52 Week Low
  • CRNX $24.10
  • KTOS $22.17
  • 52 Week High
  • CRNX $62.53
  • KTOS $76.72
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 58.12
  • KTOS 73.92
  • Support Level
  • CRNX $33.42
  • KTOS $61.40
  • Resistance Level
  • CRNX $37.23
  • KTOS $65.29
  • Average True Range (ATR)
  • CRNX 1.48
  • KTOS 3.19
  • MACD
  • CRNX -0.01
  • KTOS 0.70
  • Stochastic Oscillator
  • CRNX 56.59
  • KTOS 91.76

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

Share on Social Networks: